Establishment of different experimental asthma models in mice

Yu,Qian‑Lin; Chen,Zhangbo

doi:10.3892/etm.2018.5721

Establishment of different experimental asthma models in mice

Authors:
- Qian‑Lin Yu
- Zhangbo Chen
View Affiliations

Affiliations: School of Life Science and Technology, Shanghai Tech University, Shanghai 201210, P.R. China, Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China
Published online on: January 8, 2018 https://doi.org/10.3892/etm.2018.5721
Pages: 2492-2498
Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Asthma is a complex disease. The heterogeneity of airway inflammation during asthma indicates there are different mechanisms involved. In order to further study the mechanisms of asthma, different mouse models were established to mimic corresponding subtypes of asthma in clinic. Eosinophilic asthma was established by intraperitoneal injections of ovalbumin (OVA) on day 0 and day 7, followed by inhalation of aerosolized OVA on days 14‑17. Neutrophilic asthma was established by transtracheal administration of a high dose of lipopolysaccharide (LPS; 10 µg) on days 15 and 17 in combination with OVA sensitization and challenge as described previously. Mix‑granulocytic asthma was established by transtracheal administration of a low dose of LPS (1 µg) on day 15, in combination with OVA sensitization and challenge as described previously. Compared with healthy controls, increased numbers of eosinophils, elevated levels of T helper (Th)2 cytokines in bronchoalveolar lavage fluid (BALF), and moderated inflammation of lung tissues was observed in eosinophilic asthma. Increased numbers of neutrophils, elevated levels of Th1 and Th17 cytokines in BALF and severe inflammation of lung tissues was observed in neutrophilic asthma. Increased numbers of both eosinophils and neutrophils, elevated levels of Th1, Th2 and Th17 cytokines in BALF and severe inflammation of lung tissues was observed in mix-granulocytic asthma. Airway hyperresponsiveness, increased bronchial mucus secretion, and elevated serum levels of immunoglobin (Ig)E and OVA‑IgE were detected in all three asthma models. Dexamethasone reduced the pathogenic symptoms of the mice in eosinophilic asthma, however had no effect on neutrophilic asthma or mix‑granulocytic asthma. Each model of asthma established in the present study represents corresponding subtypes of asthma in clinic.

View Figures

View References

1	Baarnes CB, Hansen AV and Ulrik CS: Enrolment in an asthma management program during pregnancy and adherence with inhaled corticosteroids: The ‘Management of Asthma during Pregnancy’ Program. Respiration. 92:9–15. 2016. View Article : Google Scholar : PubMed/NCBI
2	Uhm TG, Kim BS and Chung IY: Eosinophil development, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma. Allergy Asthma Immunol Res. 4:68–79. 2012. View Article : Google Scholar : PubMed/NCBI
3	Thomson NC: Novel approaches to the management of noneosinophilic asthma. Ther Adv Respir Dis. 10:211–234. 2016. View Article : Google Scholar : PubMed/NCBI
4	Simpson JL, Scott R, Boyle MJ and Gibson PG: Inflammatory subtypes in asthma: Assessment and identification using induced sputum. Respirology. 11:54–61. 2006. View Article : Google Scholar : PubMed/NCBI
5	Schleich FN, Manise M, Sele J, Henket M, Seidel L and Louis R: Distribution of sputum cellular phenotype in a large asthma cohort: Predicting factors for eosinophilic vs. neutrophilic inflammation. BMC Pulm Med. 13:112013. View Article : Google Scholar : PubMed/NCBI
6	Lee MY, Seo CS, Lee NH, Ha H, Lee JA, Lee H, Lee KY and Shin HK: Anti-asthmatic effect of schizandrin on OVA-induced airway inflammation in a murine asthma model. Int Immunopharmacol. 10:1374–1379. 2010. View Article : Google Scholar : PubMed/NCBI
7	Douwes J, Gibson P, Pekkanen J and Pearce N: Non-eosinophilic asthma: Importance and possible mechanisms. Thorax. 57:643–648. 2002. View Article : Google Scholar : PubMed/NCBI
8	Peden DB: The epidemiology and genetics of asthma risk associated with air pollution. J Allergy Clin Immunol. 115:213–219; quiz 220. 2005. View Article : Google Scholar : PubMed/NCBI
9	Chang HS, Lee TH, Jun JA, Baek AR, Park JS, Koo SM, Kim YK, Lee HS and Park CS: Neutrophilic inflammation in asthma: Mechanisms and therapeutic considerations. Expert Rev Respir Med. 11:29–40. 2017. View Article : Google Scholar : PubMed/NCBI
10	Kim KH, Jahan SA and Kabir E: A review on human health perspective of air pollution with respect to allergies and asthma. Environ Int. 59:41–52. 2013. View Article : Google Scholar : PubMed/NCBI
11	Melgert BN, Postma DS, Kuipers I, Geerlings M, Luinge MA, van der Strate BW, Kerstjens HA, Timens W and Hylkema MN: Female mice are more susceptible to the development of allergic airway inflammation than male mice. Clin Exp Allergy. 35:1496–1503. 2005. View Article : Google Scholar : PubMed/NCBI
12	Chang HY, Mitzner W and Watson J: Variation in airway responsiveness of male C57BL/6 mice from 5 vendors. J Am Assoc Lab Anim Sci. 51:401–406. 2012.PubMed/NCBI
13	Freeman CM, Crudgington S, Stolberg VR, Brown JP, Sonstein J, Alexis NE, Doerschuk CM, Basta PV, Carretta EE, Couper DJ, et al: Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS). J Transl Med. 13:192015. View Article : Google Scholar : PubMed/NCBI
14	Nakajima H and Hirose K: Role of IL-23 and Th17 cells in airway inflammation in asthma. Immune Netw. 10:1–4. 2010. View Article : Google Scholar : PubMed/NCBI
15	Pelaia G, Vatrella A, Busceti MT, Gallelli L, Calabrese C, Terracciano R and Maselli R: Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma. Mediators Inflamm. 2015:8797832015. View Article : Google Scholar : PubMed/NCBI
16	Parameswaran K, Pizzichini E, Pizzichini MM, Hussack P, Efthimiadis A and Hargreave FE: Clinical judgement of airway inflammation versus sputum cell counts in patients with asthma. Eur Respir J. 15:486–490. 2000. View Article : Google Scholar : PubMed/NCBI
17	Simpson JL, Scott RJ, Boyle MJ and Gibson PG: Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am J Respir Crit Care Med. 172:559–565. 2005. View Article : Google Scholar : PubMed/NCBI
18	Gasiuniene E, Lavinskiene S, Sakalauskas R and Sitkauskiene B: Levels of IL-32 in serum, induced sputum supernatant, and bronchial lavage fluid of patients with chronic obstructive pulmonary disease. COPD. 13:569–575. 2016. View Article : Google Scholar : PubMed/NCBI
19	Emmanouil P, Loukides S, Kostikas K, Papatheodorou G, Papaporfyriou A, Hillas G, Vamvakaris I, Triggidou R, Katafigiotis P, Kokkini A, et al: Sputum and BAL Clara cell secretory protein and surfactant protein D levels in asthma. Allergy. 70:711–714. 2015. View Article : Google Scholar : PubMed/NCBI
20	Kerzel S, Wagner J, Rogosch T, Yildirim AO, Sikula L, Fehrenbach H, Garn H, Maier RF, Schroeder HW Jr and Zemlin M: Composition of the immunoglobulin classic antigen-binding site regulates allergic airway inflammation in a murine model of experimental asthma. Clin Exp Allergy. 39:591–601. 2009. View Article : Google Scholar : PubMed/NCBI
21	Thomson NC and Spears M: Inhaled corticosteroids for asthma: On-demand or continuous use. Expert Rev Respir Med. 7:687–699. 2013. View Article : Google Scholar : PubMed/NCBI
22	Raissy HH, Kelly HW, Harkins M and Szefler SJ: Inhaled corticosteroids in lung diseases. Am J Respir Crit Care Med. 187:798–803. 2013. View Article : Google Scholar : PubMed/NCBI
23	Simpson JL, Gibson PG, Yang IA, Upham J, James A, Reynolds PN and Hodge S; AMAZES Study Research Group, : Impaired macrophage phagocytosis in non-eosinophilic asthma. Clin Exp Allergy. 43:29–35. 2013. View Article : Google Scholar : PubMed/NCBI
24	Huang SK, Zhang Q, Qiu Z and Chung KF: Mechanistic impact of outdoor air pollution on asthma and allergic diseases. J Thorac Dis. 7:23–33. 2015.PubMed/NCBI
25	Tosca MA, Silvestri M, Morandi F, Prigione I, Pistorio A, Ciprandi G and Rossi GA: Impairment of lung function might be related to IL-10 and IFN-γ defective production in allergic children. Immunol Lett. 140:104–106. 2011. View Article : Google Scholar : PubMed/NCBI
26	Newcomb DC and Peebles RS Jr: Th17-mediated inflammation in asthma. Curr Opin Immunol. 25:755–760. 2013. View Article : Google Scholar : PubMed/NCBI
27	Furukawa T, Sakagami T, Koya T, Hasegawa T, Kawakami H, Kimura Y, Hoshino Y, Sakamoto H, Shima K, Tsukioka K, et al: Characteristics of eosinophilic and non-eosinophilic asthma during treatment with inhaled corticosteroids. J Asthma. 52:417–422. 2015. View Article : Google Scholar : PubMed/NCBI
28	Manise M, Bakayoko B, Schleich F, Corhay JL and Louis R: IgE mediated sensitisation to aeroallergens in an asthmatic cohort: Relationship with inflammatory phenotypes and disease severity. Int J Clin Pract. 70:596–605. 2016. View Article : Google Scholar : PubMed/NCBI
29	Gao P, Gibson PG, Baines KJ, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, et al: Anti-inflammatory deficiencies in neutrophilic asthma: Reduced galectin-3 and IL-1RA/IL-1β. Respir Res. 16:52015. View Article : Google Scholar : PubMed/NCBI
30	Bafadhel M, McCormick M, Saha S, McKenna S, Shelley M, Hargadon B, Mistry V, Reid C, Parker D, Dodson P, et al: Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration. 83:36–44. 2012. View Article : Google Scholar : PubMed/NCBI
31	Al-Ramli W, Préfontaine D, Chouiali F, Martin JG, Olivenstein R, Lemière C and Hamid Q: T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol. 123:1185–1187. 2009. View Article : Google Scholar : PubMed/NCBI
32	Lajoie S, Lewkowich IP, Suzuki Y, Clark JR, Sproles AA, Dienger K, Budelsky AL and Wills-Karp M: Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol. 11:928–935. 2010. View Article : Google Scholar : PubMed/NCBI
33	Hansen G, Berry G, DeKruyff RH and Umetsu DT: Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest. 103:175–183. 1999. View Article : Google Scholar : PubMed/NCBI
34	Hering T: Update of the GINA-recommendations. MMW Fortschr Med. 159:63–64. 2017.(In German). View Article : Google Scholar : PubMed/NCBI
35	Isidoro-García M, Sánchez-Martín A, García-Sánchez A, Sanz C, García-Berrocal B and Dávila I: Pharmacogenetics and the treatment of asthma. Pharmacogenomics. 18:1271–1280. 2017. View Article : Google Scholar : PubMed/NCBI